Provenance Wealth Advisors LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,718 shares of the financial services provider’s stock, valued at approximately $450,000.
Other institutional investors also recently made changes to their positions in the company. First Nebraska Trust Co bought a new position in CME Group during the 3rd quarter worth $517,000. Stiles Financial Services Inc lifted its stake in CME Group by 6.1% in the third quarter. Stiles Financial Services Inc now owns 15,237 shares of the financial services provider’s stock valued at $3,992,000 after buying an additional 870 shares during the last quarter. CrossGen Wealth LLC lifted its stake in CME Group by 5.0% in the third quarter. CrossGen Wealth LLC now owns 7,053 shares of the financial services provider’s stock valued at $1,848,000 after buying an additional 337 shares during the last quarter. Signature Equity Partners LLC lifted its stake in CME Group by 28.3% in the third quarter. Signature Equity Partners LLC now owns 467 shares of the financial services provider’s stock valued at $122,000 after buying an additional 103 shares during the last quarter. Finally, Kuhn & Co Investment Counsel acquired a new position in shares of CME Group during the third quarter valued at $319,000. 87.75% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on CME shares. JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price target for the company in a report on Thursday, October 22nd. Piper Sandler reaffirmed an “overweight” rating and issued a $330.00 price objective (up from $295.00) on shares of CME Group in a report on Thursday, October 22nd. Weiss Ratings upgraded shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, October 23rd. Wells Fargo & Company lifted their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Finally, CLSA set a $367.00 target price on shares of CME Group in a research note on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus price target of $314.44.
Insider Activity
In other news, insider Sunil Cutinho sold 5,000 shares of CME Group stock in a transaction on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the transaction, the insider directly owned 20,037 shares in the company, valued at approximately $5,985,051.90. This trade represents a 19.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Julie Winkler sold 10,079 shares of the business’s stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the sale, the insider directly owned 21,482 shares in the company, valued at $6,555,232.30. This represents a 31.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 32,979 shares of company stock worth $9,552,762 in the last quarter. 0.30% of the stock is currently owned by corporate insiders.
CME Group Trading Down 0.3%
CME Group stock opened at $307.24 on Friday. The firm has a 50 day simple moving average of $282.60 and a 200-day simple moving average of $280.66. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $109.97 billion, a PE ratio of 25.20, a price-to-earnings-growth ratio of 3.76 and a beta of 0.15. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same quarter in the previous year, the company earned $2.68 earnings per share. The firm’s quarterly revenue was up 10.6% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 12.34 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is presently 42.66%.
About CME Group
CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.
CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.
Read More
- Five stocks we like better than CME Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
